Personal information

Verified email domains

Activities

Employment (3)

University of South Australia: Adelaide, SA, AU

2013-01-01 to present | Lab Head, gene regulatory networks laboratory (Centre for Cancer Biology)
Employment
Source: Self-asserted source
Cameron Bracken

SA Pathology: Adelaide, SA, AU

2008-01-07 to present | Post-doctoral Research Fellow (Centre for Cancer Biology)
Employment
Source: Self-asserted source
Cameron Bracken

University of Dundee: Dundee, Scotland, GB

2005-01-05 to 2007-12-20 | Post-doctoral research fellow
Employment
Source: Self-asserted source
Cameron Bracken

Education and qualifications (1)

University of Adelaide: Adelaide, SA, AU

2001-02-01 to 2005-12-21 | PhD (Molecular Life Sciences)
Qualification
Source: Self-asserted source
Cameron Bracken

Professional activities (4)

University of Adelaide: Adelaide, SA, AU

Affiliate senior lecturer (Medicine, Life Sciences)
Invited position
Source: Self-asserted source
Cameron Bracken

Australian Society of Biochemistry and Molecular Biology: National society, AU

Membership
Source: Self-asserted source
Cameron Bracken

Australasian RNA Biology and Biotechnology (A-RNA) Association: Adelaide, AU

2024-01-01 to present
Membership
Source: Self-asserted source
Cameron Bracken

University of South Australia: Adelaide, South Australia, AU

2021-12-07 | Associate Professorship
Distinction
Source: Self-asserted source
Cameron Bracken

Funding (10)

Basonuclin-2, a new regulator of breast cancer stemness and chemo-resistance

2021-03 to 2022-03 | Grant
The Hospital Research Foundation (Adelade, AU)
GRANT_NUMBER:

2021/11-QA25290

Source: Self-asserted source
Cameron Bracken

Hidden complexity in microRNA function

2019-01-01 to 2022-12-31 | Grant
Australian Research Council (Canberra, AU)
GRANT_NUMBER: FT190100544
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

MicroRNA combinations as a therapeutic strategy

2019-01-01 to 2021-12-31 | Grant
Worldwide Cancer Research (Edinburgh, GB)
GRANT_NUMBER:

WCR-19-0300

Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Transcriptional regulation by microRNAs

2019-01-01 to 2021-12-31 | Grant
Australian Research Council (Canberra, AU)
GRANT_NUMBER: DP190103333
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Using miR-200 to find new therapeutic targets for neuroblastoma

2017-01-01 to 2019-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1129353
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

How isomiRs expand the microRNA functional repertoire in affecting gene expression

2014-01-01 to 2016-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1069128
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Uncovering global patterns of miRNA-mediated gene regulation in Epithelial-Mesenchymal Transition

2012-09-01 to 2015-08-31 | Grant
Worldwide Cancer Research (Edinburgh, GB)
GRANT_NUMBER:

WCR-12-1170

Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Targets of epithelial microRNAs

2012-01-01 to 2014-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1034633
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Regulation of the actin cytoskeleton by miR-200

2011-01-01 to 2013-12-31 | Grant
National Health and Medical Research Council (Canberra, AU)
GRANT_NUMBER: 1008327
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Investigating the role of microRNAs in breast cancer metastasis and proliferation

2009-01-01 to 2012-12-31 | Grant
National Breast Cancer Foundation (Sydney, AU)
GRANT_NUMBER: PF-09-03
Source: Self-asserted source
Cameron Bracken via DimensionsWizard

Peer review (14 reviews for 9 publications/grants)

Review activity for BMC biology. (1)
Review activity for British journal of cancer. (1)
Review activity for Cancer letters. (2)
Review activity for Cell death and disease. (1)
Review activity for EMBO reports. (1)
Review activity for iScience. (1)
Review activity for Molecular therapy oncolytics. (1)
Review activity for Molecular therapy. (4)
Review activity for Oncogene. (2)